Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Surgery, Chemotherapy, and Radiotherapy in Invasive Urothelial Cancer
NCT00006111Phase 2Completed
- Sponsor
- Unicancer
- Start
- Apr 1999
- Primary completion
- Jan 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of cisplatin and fluorouracil in urothelial carcinoma (UC) (2 arms), sponsored by Unicancer. Primary endpoint: Quality of Life at 1 year. Started Apr 1999; status: completed.
02
Drugs
cisplatinfluorouracil
03
Conditions
urothelial carcinoma (UC)
Beyond the preview
Go deeper on NCT00006111.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00006111.